SEC Form 4 · accession 0001193125-26-255812
MDxHealth SA · MDXH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael McGarrity
Officer — Chief Executive Officer · Director
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 5:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001872529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share OptionF1 | $0.76 | Jun 1, 2026 | A | 329,800 | A | — | May 28, 2036 | Ordinary Shares | 329,800 | 329,800 | D |
| Share OptionF2 | $0.76 | Jun 1, 2026 | A | 612,400 | A | — | May 28, 2036 | Ordinary Shares | 612,400 | 612,400 | D |
Explanation of responses
- F1Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
- F2Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant.